Texas runs out of antibody treatment effective against omicron

Five regional infusion centers in Texas have run out of sotrovimab, the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant, the Department of Health and Human Services said Dec. 27.

Advertisement

The agency said centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands have exhausted their supplies of the treatment, citing national scarcity. The agency added that affected centers will not be able to offer sotrovimab until the government ships more supplies in January. 

Antibodies as prescribed by providers for patients diagnosed with non-omicron cases will continue to be administered.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.